<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04705285</url>
  </required_header>
  <id_info>
    <org_study_id>11145</org_study_id>
    <nct_id>NCT04705285</nct_id>
  </id_info>
  <brief_title>Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence</brief_title>
  <acronym>EFFECT</acronym>
  <official_title>Erbium:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence: a Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to assess the feasibility and safety to run a randomized controlled&#xD;
      trial that compared the effectivity of erbium:yag vaginal laser versus pelvic floor training&#xD;
      in women with mild to moderate stress urinary incontinence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study attempts to demonstrated the feasibility and security to run a randomized&#xD;
      controlled study that compared the effectivity of erbium:yag laser used vaginally versus&#xD;
      pelvic floor training, coached by a physiotherapist expert in pelvic floor disorders.&#xD;
&#xD;
      Patients are going to be randomized to pelvic floor exercises (10 sessions) or erbium:yag&#xD;
      laser (2 sessions), and assess the results at 6 and 12 moths later on.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Anticipated">September 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>The questionnaire will be applied at baseline, 6 month and 1 year</time_frame>
    <description>In order to measure quality of life, we are going to use the International Consultation on Incontinence Questionnaire Short Form (ICQI-SF), validate to spanish and in Chile. A higher score in this scale means a worse outcome for the patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pad test</measure>
    <time_frame>at baseline, 6 month and 1 year</time_frame>
    <description>A 24 h Pad test will be applied. The pad will be weighted after 24 h of use and the difference between the dry pad and the wet pad is going to be recorded. A great difference means a worse outcome for the patient.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Erbium:Yag Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients allocated to the erbium:yag laser are going to undergo 2 sessions of vaginal laser, separated by one month each other.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pelvic floor training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Erbium Yag Laser</intervention_name>
    <description>Subjets in the laser arm will undergo 2 sessions of vaginal erbium-yag laser, separated by a month</description>
    <arm_group_label>Erbium:Yag Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pelvic Floor Training</intervention_name>
    <description>Patients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist</description>
    <arm_group_label>Pelvic floor training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mild to Moderated Stress Urinary Incontinence&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mixed Urinary incontinence&#xD;
&#xD;
          -  Pelvic organ prolase greater than stage 2&#xD;
&#xD;
          -  Previous surgery for stress urinary incontinence and/or pelvic organ prolapse&#xD;
&#xD;
          -  Severe Stress urinary incontinence&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Victor A Miranda, MD</last_name>
    <phone>+56988291697</phone>
    <email>vmirandah@med.puc.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sebastian Viguera, MD</last_name>
    <phone>+56993316816</phone>
    <email>sebastian.viguera@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clinico de La Florida</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Viguera, MD</last_name>
      <phone>+56993316816</phone>
      <email>sebastian.viguera@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Victor Miranda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Viguera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarita Donoso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gloria Alonso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 1, 2020</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

